In AGS GC cells, metformin suppresses EMT-related genes, decreasing mesenchymal markers (vimentin and β-catenin) and promoting epithelial markers (E-cadherin), and also inhibits migration and invasiveness under hyperglycaemic conditions [99]. This evidence concerns the gene VIM and gastric cancer.